Clinical trials: Human African Trypanosomiasis
Trypanosoma Brucei Rhodesiense; Infection
A Retrospective Analysis of Suramin Treatment for Stage 1 TBR
The study will include TBR HAT patients treated with suramin between 2000 and 2020 at three sites in Uganda and Malawi A natural history cohort composed of source data from approximately 200 patients from a published…
- Trial name
- NCT06060600
- Where
- United States
- Volunteers
- 345 people
- Sponsor
- Paxmedica
Sleeping Sickness, Trypanosomiasis, African
Screen and Treat Implementation for HAT Control
Human African Trypanosomiasis (HAT), or sleeping sickness, is one of the parasitic diseases targeted for interruption of transmission by 2030 by the WHO.
- Trial name
- NCT05645822
- Testing
- Screen&treat
- Sponsor
- Institute of Tropical Medicine, Belgium